ObjectiveGI is delivering provider partners and their patients participating in research a new, all-inclusive platform of clinical research data management.
NASHVILLE, TN, July 10, 2019 – ObjectiveGI is delivering a new an all-inclusive platform of clinical research data management to partner physician groups and their patients participating in research. The combination of a traditional clinical trial management system (CTMS) with complete electronic source data allows sites to improve quality, efficiency and traceability.
“Our distributed technology further strengthens ObjectiveGI’s relationships with partner physicians by delivering more information and analytics within the framework of their existing patient care workflows,” says Colleen Hoke, president and CEO, ObjectiveGI. “This ‘frictionless’ information-sharing approach supports mobile engagement for investigators, improving workflow integration and timely access to clinical research data.”
The new ObjectiveGI platform incorporates a clinical research-based eSource model that accepts multiple data formats and securely transforms those data sets into more comprehensive reporting and analytics. The result is usable information that can be readily reviewed and utilized within trial management.
“This collaboration extends our data-driven solutions platform while maintaining our stringent security and data privacy requirements. The Clinical Research IO product infrastructure adheres to a stringent cloud-readiness process with security reviews, penetration testing and redundancy,” says Gerry Andrady, CTO, ObjectiveGI.
ObjectiveGI is engaging next generation research systems to leverage resources and accelerate high-quality data collection, thus allowing for more efficient research execution throughout the patient care continuum.
ObjectiveGI, Inc. is an integrated research and technology services platform company that establishes “Center of Research Excellence” partnerships with gastroenterology physician practices, providing research infrastructure, optimal trial selection, study implementation and key research personnel management. Its proprietary processes and technology eliminate the healthcare workflow disruptions commonly associated with clinical trials, thus enabling the delivery of a valuable ancillary vertical that transforms care and improves health outcomes. ObjectiveGI’s initial focus is nonalcoholic steatohepatitis (NASH), a silent chronic disease that affects millions of Americans. Learn more about ObjectiveGI at www.ObjectiveGI.com.
Clinical Research IO, LLC (CRIO) is the industry’s leading integrated eSource, eRegulatory and CTMS software vendor. With their easy-to-use, powerful all-in-one eSource, eRegulatory and CTMS system, they have helped hundreds of sites across the globe grow. Built for research sites and cofounded by a former research site owner, CRIO is passionate about transforming and supporting clinical research through innovation. CRIO is excited to partner with ObjectiveGI to deliver a seamless clinical trial experience to its provider partners.
Contact:
Colleen Hoke, ObjectiveGI
Jillian Hammell, Crowley Webb
jillian.hammell@crowleywebb.com; 716 856 2932 x237
